Merz Launches New Belotero® Revive Dermal Filler
Merz, a global leader in medical aesthetics, today announced the launch of Belotero® Revive, a dermal filler product containing a unique combination of hyaluronic acid (HA) and glycerol, designed to improve hydration, elasticity and firmness of the skin and to address the appearance of fine lines.1,2 The newest addition to the Belotero® dermal filler range, Belotero® Revive was designed to meet the unique needs of today’s aesthetic patients. Modern consumers are especially focused on skin quality and on minimizing early signs of aging, and they value skincare and aesthetic solutions that deliver natural-looking results – the so-called “no-filter” look.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20190405005040/en/
Learn more at BeloteroRevive.com (Photo: Business Wire)
“We continue to see a growing interest in effective, high quality injectable treatments from a new generation of aesthetic patients, due in part to the influence of social media and other digital channels,” stated Prof. Dr. Martina Kerscher, Professor of Dermatology, University of Hamburg and lead author of the BELOVE study. “Strong scientific research forms the basis for this new dermal injectable and our study results show that treatment with this beauty booster is a an effective way to provide direct skin hydration and increase skin smoothness, giving our patients beautiful, natural-looking results.” 3,4
The new Belotero® Revive campaign encourages consumers to “Show off the best version of yourself, without a filter!” The campaign hints playfully at the influence of the digital sphere on real-life moments and is designed to speak to the growing acceptance of aesthetic medicine in different age groups, while encouraging female consumers to make choices that bring out their own individual and natural beauty.
“Customer research and market trends make it clear that a new generation of patients is increasingly open to aesthetic medicine and actively looking for options to treat the first visible signs of aging,” stated Philip Burchard, CEO of Merz. “At Merz, we have a strong focus on researching and developing innovative and effective solutions that can be used to address both specific patient needs and new market trends in medical aesthetics. With Belotero® Revive, we are proud to be able to provide aesthetic physicians with a new dermal injectable that can be used for both early intervention and beautification, to help meet the unique needs of individual patients.”
Belotero® Revive is now available in selected countries in Europe and Latin America, with additional markets to be added later this year. For more details, please visit BeloteroRevive.com or follow @Merz_Aesthetics on Instagram.
Belotero® Revive builds upon the success of the well-established Belotero® range, which includes a wider selection of fillers which can correct imbalances and facial volume-loss, define contours, lift, volumize, fill lines and wrinkles. More information about the full Belotero® range is available at global.belotero.com.
About Belotero ® Revive
Belotero® Revive is applied via injection over multiple treatments working as a beauty booster and for an overall youthful radiance. It works beneath the skin to provide hydration but can also be used to reduce the appearance of fine lines, or as a preventative and early aesthetic intervention treatment to slow the progression of facial changes over time.4 Belotero® Revive was clinically assessed in a study involving 24 patients. Belotero® Revive was injected into the lower cheek area of the face the treatment options have been tested in an observation period of over 36 weeks.4
Results of the BELOVE study 4
Belotero® Revive improves skin elasticity, has an excellent safety profile, and a generally lower level of injection site pain
- Up to 36 weeks improved skin hydration and reduced skin redness
- 100% of patients showed improved aesthetic results at week 12
- Over 80% of patients were satisfied with the treatment at week 24
- 90% of patients would recommend Belotero® Revive to friends
About Merz
Merz is a global, family-owned aesthetics and neurotoxin company based in Frankfurt, Germany. Privately-held for 110 years, the company is distinguished by its commitment to innovation, long-term perspective and focus on profitable growth. In addition to its comprehensive portfolio of medical aesthetics products across the device, injectable and skincare categories, Merz also develops neurotoxin therapy to treat neurologically-induced movement disorders. In fiscal year 2017/18, Merz generated revenue of EUR 1.024,4 million; the company has a total workforce of 3,151 employees worldwide and a direct presence in 28 countries. More information is available at www.merz.com.
Copyright © 2019 Merz Pharma GmbH & Co. KGaA. All rights reserved. MERZ, MERZ AESTHETICS and the MERZ logo are registered trademarks of Merz Pharma GmbH & Co. KgaA.
1 HA in rejuvenation: Bukhari et al., Int J Biol
Macromolecules, 2018; 120:1682-1695
2 Glycerol and
hydration: Korponyai C et al., Acta Derm Venerol, 2017; 97:182-187
3
Belotero® Revive Instruction for use Version 3.0, 2018
4
Merz BELOVE Study, 2019
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20190405005040/en/
Contact information
Media
Merz Pharma GmbH & Co. KGaA
Global
Communications
Mariana Smith Bourland
Phone: +49 151 4249 1466
Email:
mariana.smith@merz.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Spatial Releases 2025 1.0.1 with Enhancements for CAD Translation, Model Simplification, and Mesh Preparation for Manufacturing and Simulation2.5.2025 17:47:00 EEST | Press release
Spatial Corp., the leading software development toolkit provider for design, manufacturing and engineering solutions and a subsidiary of Dassault Systèmes, announces the 2025 1.0.1 release and updates across several product lines, reaffirming its commitment to providing innovative solutions for its customers in domains ranging from CAD to simulation, manufacturing, and beyond. The 2025 1.0.1 release delivers expanded functionality designed to streamline manufacturing and simulation workflows. Key highlights include a new custom feature detection API in ACIS for more efficient model simplification, expanded CAD format support—including STEP AP242 PMI writing—and continued enhancements to hidden-body removal. With this release, Spatial reduces manual tasks, increases fidelity in geometry translation, and strengthens its toolset for automated design-to-manufacture and design-to-simulation pipelines. 3D ACIS Modeler Custom Feature Detection (Beta): Model simplification often requires manua
Decent Cybersecurity Joins the Council of Slovak Exporters to Strengthen European Cybersecurity Exports2.5.2025 16:51:00 EEST | Press release
Decent Cybersecurity, a leading European provider of post-quantum security solutions, announces its membership in the Council of Slovak Exporters (CSE), reinforcing its commitment to expanding advanced cybersecurity exports across global markets. This strategic partnership combines Decent Cybersecurity's expertise in critical infrastructure protection with CSE's established export promotion platform. As a company holding national, EU, and NATO "Secret" level security clearances, Decent Cybersecurity brings specialized knowledge in post-quantum security, blockchain technology, and space traffic management solutions to the Council's network. "Joining the Council of Slovak Exporters represents a significant opportunity to strengthen Slovakia's position in the global cybersecurity market," said Matej Michalko, Founder and CEO of Decent Cybersecurity and a long-term expert on post-quantum cryptography and blockchain. "As cyber threats continue to evolve, our advanced solutions are increasin
Saudi Arabia Hosts EDGEx 2025, Pushing the Boundaries of Education2.5.2025 16:29:00 EEST | Press release
Saudi Arabia has taken another step forward in its educational reform journey with the successful conclusion of the International Education Exhibition (EDGEx), held from April 13–16, 2025. Organized by the Ministry of Education, the event convened education leaders, technology developers, and policymakers from around the world under the theme “Beyond Readiness.” This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250502190798/en/ Saudi Arabia Hosts EDGEx 2025, Pushing the Boundaries of Education (Photo: AETOSWire) Over four days, EDGEx welcomed more than 20,000 local and international visitors, including government representatives, senior educators, academics, business leaders, and professionals in the field. The exhibition served as a platform for dialogue, knowledge exchange, and cross-sector collaboration—bringing together institutions, companies, and decision-makers to explore how education and training can evolve in a rapidl
IFF Announces Tender Offers for Certain Outstanding Series of Notes2.5.2025 16:10:00 EEST | Press release
IFF (NYSE: IFF) announced today the commencement of tender offers to purchase for cash certain of its outstanding series of notes listed in the tables below (collectively, the “Notes”) for an aggregate purchase price, excluding accrued and unpaid interest, of up to $1.8 billion. Pool 1 Tender Offers Pool 1 Maximum Amount: $1.0 billion(1(a)) Title of Security CUSIP/ISIN Principal Amount Outstanding(in millions) Acceptance Priority Level(2) Series Tender Cap(3) U.S. Treasury Reference Security Bloomberg Reference Page Fixed Spread(4) Early Tender Payment (4)(5) 1.230% Senior Notes due 2025 459506AN1 U45950AE9 $1,000 1 $500 million 5.000% UST due 9/30/25 FIT3 + 0 bps $30 1.832% Senior Notes due 2027 459506AP6 U45950AF6 $1,200 2 $300 million 3.750% UST due 4/30/27 FIT1 + 75 bps $30 2.300% Senior Notes due 2030 459506AQ4 U45950AG4 $1,500 3 N/A 3.875% UST due 4/30/30 FIT1 + 110 bps $30 4.450% Senior Notes due 2028 459506AK7 US459506AK78 $400 4 N/A 3.750% UST due 4/15/28 FIT1 + 95 bps $30 Poo
Heidrick & Struggles Appoints a New Managing Partner for Their CEO & Board Practice in Europe and Africa2.5.2025 11:27:00 EEST | Press release
Heidrick & Struggles (Nasdaq: HSII), a premier provider of executive search, global leadership advisory and on-demand talent solutions, has appointed Kati Najipoor-Smith as Regional Co-Managing Partner, CEO & Board Practice, for Europe and Africa. Based at the Firm’s office in Frankfurt, Germany, Kati brings decades of global executive search and consulting experience to the Heidrick & Struggles team to support boards and CEOs in navigating complex leadership challenges. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250501269229/en/ Kati Najipoor-Smith has been appointed Heidrick & Struggles' Regional Co-Managing Partner, CEO & Board Practice, for Europe and Africa Kati began her executive search career at Egon Zehnder in 1999, where she led Global Automotive and later the Global CEO Practice over several years. She advises chairs and CEOs of publicly traded, family-owned, and private-equity-backed companies across sectors
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom